Login
Canopy Growth NYSE: CGC
From product and process innovation to market execution and everything in between, we are driven by a passion for …. providing medical and recreational cannabis consumers the best possible experience
| Name | Canopy Growth |
| Ticker | CGC |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Cannabis Specialties |
| Price | 29.00 |
| 52W Low/High | 9.73 / 29.00 |
| Market cap | 11 B |
| 1Y Total Return |
56.00%
Strong |
| 1Y Volatility |
80.54%
High Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
From product and process innovation to market execution and everything in between, we are driven by a passion for …. providing medical and recreational cannabis consumers the best possible experience
Details
| Ticker | CGC |
| Name | Canopy Growth |
| ISIN | CA1380351009 |
| CUSIP | |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Cannabis Specialties |
| Country | Canada |
| Currency | U.S. Dollar |
Share as of 11/27/20
| Close Price | 29.00 |
| 52W Low/High | 9.73 / 29.00 |
| Market cap | 11 B |
| 1Y Total Return |
56.00%
Strong |
| 1Y Volatility |
80.54%
High Risk |
| Beta | 1.71 |
| PE (trailing) |
65.37
High |
| 12M Dividends | - |
| Last Dividend Date | - |
| Dividend Yield | - |
Fin. Strength
| Net Profit Margin | 40.9% |
| Cash from Op. / Cur. Liabilities | -2.14 |
| Diluted Earnings / Share | 0.44 |
| ROE | 3.8% |
| ROIC | 0.4% |
| Price / Revenue | 30.0 |
| Price / Book | 2.9 |
| Price / CF | -20.7 |
| Current Ratio | 7.1 |
| Cur.Liabilities / Tot.Liabilities | 0.2 |
| Financial Leverage | 0.11 |
| in Mils USD |
rolling-year up to September
|
||||
|---|---|---|---|---|---|
| Income Statement | 2020 | 2019 | 2018 | 2017 | |
| Revenue |
359
|
263
|
71
|
46
|
|
| Gross Profit |
-
|
30
|
-
|
52
|
|
| R&D |
-15
|
-2
|
2
|
0
|
|
| EBITDA |
148
|
-120
|
-343
|
-
|
|
| Operating Income |
-1,306
|
-670
|
-273
|
-17
|
|
| Net Income exc. Extra |
147
|
-
|
-
|
-
|
|
| per Share | |||||
| Diluted avg Shares |
372
|
380
|
222
|
-
|
|
| EPS exc. Extra |
0.44
|
-1.51
|
-1.70
|
-
|
|
| Dividend |
-
|
-
|
-
|
-
|
|
| Div. Yield (an.) |
-
|
-
|
-
|
-
|
|
| Balance Sheet | 2020 | 2019 | 2018 | 2017 | |
| Total Assets |
4,943
|
6,279
|
2,255
|
-
|
|
| Cash, Eq & Invt ShortTerm |
1,306
|
2,089
|
325
|
-
|
|
| Total Current Assets |
1,723
|
2,724
|
532
|
-
|
|
| Total Non-Current Assets |
3,219
|
3,555
|
1,722
|
-
|
|
| Intangibles |
1,783
|
1,852
|
923
|
-
|
|
| Total Liabilities |
1,068
|
1,987
|
860
|
-
|
|
| Total Current Liabilities |
244
|
325
|
826
|
-
|
|
| Long Term Debt |
824
|
1,662
|
34
|
-
|
|
| Shareholder equity |
3,698
|
4,085
|
1,236
|
-
|
|
| Cash Flow | 2020 | 2019 | 2018 | 2017 | |
| Cash from Operations |
-522
|
-541
|
-195
|
-
|
|
| Depreciation |
105
|
59
|
20
|
-
|
|
| Cash from Investing |
15
|
-2,891
|
-429
|
-
|
|
| Capex |
594
|
906
|
336
|
-
|
|
| Cash from Financing |
202
|
3,899
|
866
|
-
|
|
| Stock Issued |
197
|
3,989
|
438
|
-
|
|
| Debt (LT) Issued |
5
|
-79
|
441
|
-
|
|
| Free Cash Flow |
11
|
-3,103
|
-
|
-
|
|
| Ratios | 2020 | 2019 | 2018 | 2017 | |
| Net Profit Margin |
40.9%
|
-
|
-
|
-
|
|
| NCFO / Op.Income |
-
|
-
|
-
|
-
|
|
| Current Ratio |
7.1
|
8.4
|
0.6
|
-
|
|
| Financial Leverage D/E |
0.11
|
0.11
|
0.56
|
-
|
|
| Return on Capital Avg |
0.4%
|
-5.9%
|
-50.8%
|
-
|
|
| Return on Shareholder Equity |
3.8%
|
-
|
-
|
-
|
|
Fundamentals
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available